Travere Therapeutics, Inc.

Q1 2026 13F Holders

Symbol
TVTX
CUSIP
89422G107
Type
Equity
Class
COM
Num filings
283
Total reported value, excl. options
$3.01 B
Manager Report Date Value ($000) Shares Option Type